Cargando…

Cholesterol goals, statin use and residual cardiovascular risk estimated by SMART score: Study of a Nicaraguan population

INTRODUCTION: Adverse cardiovascular events that arise in patients with established cardiovascular disease have prompted researchers to seek variables that can help estimate residual cardiovascular risk and aid in its reduction. In Latin-America, there is limited data assessing this type of risk. OB...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizo Rivera, Ginner Odorico, Valladares, Marion Jose, Toledo Vargas, Hildebrando M., Chavez, Elibeth, Garcia de la Rocha, Alejandro A., Urcuyo Hernandez, Luis A., Meneses Mercado, Jose Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328960/
https://www.ncbi.nlm.nih.gov/pubmed/37427093
http://dx.doi.org/10.1016/j.ijcrp.2023.200192
_version_ 1785069919244648448
author Rizo Rivera, Ginner Odorico
Valladares, Marion Jose
Toledo Vargas, Hildebrando M.
Chavez, Elibeth
Garcia de la Rocha, Alejandro A.
Urcuyo Hernandez, Luis A.
Meneses Mercado, Jose Daniel
author_facet Rizo Rivera, Ginner Odorico
Valladares, Marion Jose
Toledo Vargas, Hildebrando M.
Chavez, Elibeth
Garcia de la Rocha, Alejandro A.
Urcuyo Hernandez, Luis A.
Meneses Mercado, Jose Daniel
author_sort Rizo Rivera, Ginner Odorico
collection PubMed
description INTRODUCTION: Adverse cardiovascular events that arise in patients with established cardiovascular disease have prompted researchers to seek variables that can help estimate residual cardiovascular risk and aid in its reduction. In Latin-America, there is limited data assessing this type of risk. OBJECTIVE: Estimate residual cardiovascular risk in ambulatory patients diagnosed with Chronic Coronary Syndrome (CCS) using the SMART-Score scale seen at five clinics in Nicaragua; determine the prevalence of patients that achieve a serum LDL level of <55 mg/dL; and describe the use of statins in these patients. METHODS: A total of 145 participants previously diagnosed with CCS seen regularly in ambulatory visits were enrolled. A survey was completed, including epidemiological variables that allowed the calculation of a SMART score. Data analysis was conducted using SPSS version 21.0. RESULTS: A 46.2% of participants were male, the average age was 68.7 years (11.4 SD), 91% had hypertension, 80.7% had a BMI ≥25. Under the SMART Score risk classification per Dorresteijn et al. the following risk distribution was found: 2.8% low, 31% moderate, 20% high, 13.1% very high and 33.1% extremely high. Per the risk classification of Kaasenbrood et al., 2.8% were in the 0–9% group, 31% in the 10–19%, 20% in 20–29% and 46.2% were in the ≥30% group. A 64.8% did not meet LDL goals. CONCLUSION: There is an inadequate control of cLDL levels in patients with CCS, and the appropriate available therapeutic resources aren't being utilized. It is important to achieve a proper control of lipid levels in order to improve cardiovascular outcomes, despite currently being far from these goals.
format Online
Article
Text
id pubmed-10328960
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103289602023-07-09 Cholesterol goals, statin use and residual cardiovascular risk estimated by SMART score: Study of a Nicaraguan population Rizo Rivera, Ginner Odorico Valladares, Marion Jose Toledo Vargas, Hildebrando M. Chavez, Elibeth Garcia de la Rocha, Alejandro A. Urcuyo Hernandez, Luis A. Meneses Mercado, Jose Daniel Int J Cardiol Cardiovasc Risk Prev Research Paper INTRODUCTION: Adverse cardiovascular events that arise in patients with established cardiovascular disease have prompted researchers to seek variables that can help estimate residual cardiovascular risk and aid in its reduction. In Latin-America, there is limited data assessing this type of risk. OBJECTIVE: Estimate residual cardiovascular risk in ambulatory patients diagnosed with Chronic Coronary Syndrome (CCS) using the SMART-Score scale seen at five clinics in Nicaragua; determine the prevalence of patients that achieve a serum LDL level of <55 mg/dL; and describe the use of statins in these patients. METHODS: A total of 145 participants previously diagnosed with CCS seen regularly in ambulatory visits were enrolled. A survey was completed, including epidemiological variables that allowed the calculation of a SMART score. Data analysis was conducted using SPSS version 21.0. RESULTS: A 46.2% of participants were male, the average age was 68.7 years (11.4 SD), 91% had hypertension, 80.7% had a BMI ≥25. Under the SMART Score risk classification per Dorresteijn et al. the following risk distribution was found: 2.8% low, 31% moderate, 20% high, 13.1% very high and 33.1% extremely high. Per the risk classification of Kaasenbrood et al., 2.8% were in the 0–9% group, 31% in the 10–19%, 20% in 20–29% and 46.2% were in the ≥30% group. A 64.8% did not meet LDL goals. CONCLUSION: There is an inadequate control of cLDL levels in patients with CCS, and the appropriate available therapeutic resources aren't being utilized. It is important to achieve a proper control of lipid levels in order to improve cardiovascular outcomes, despite currently being far from these goals. Elsevier 2023-06-23 /pmc/articles/PMC10328960/ /pubmed/37427093 http://dx.doi.org/10.1016/j.ijcrp.2023.200192 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Paper
Rizo Rivera, Ginner Odorico
Valladares, Marion Jose
Toledo Vargas, Hildebrando M.
Chavez, Elibeth
Garcia de la Rocha, Alejandro A.
Urcuyo Hernandez, Luis A.
Meneses Mercado, Jose Daniel
Cholesterol goals, statin use and residual cardiovascular risk estimated by SMART score: Study of a Nicaraguan population
title Cholesterol goals, statin use and residual cardiovascular risk estimated by SMART score: Study of a Nicaraguan population
title_full Cholesterol goals, statin use and residual cardiovascular risk estimated by SMART score: Study of a Nicaraguan population
title_fullStr Cholesterol goals, statin use and residual cardiovascular risk estimated by SMART score: Study of a Nicaraguan population
title_full_unstemmed Cholesterol goals, statin use and residual cardiovascular risk estimated by SMART score: Study of a Nicaraguan population
title_short Cholesterol goals, statin use and residual cardiovascular risk estimated by SMART score: Study of a Nicaraguan population
title_sort cholesterol goals, statin use and residual cardiovascular risk estimated by smart score: study of a nicaraguan population
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328960/
https://www.ncbi.nlm.nih.gov/pubmed/37427093
http://dx.doi.org/10.1016/j.ijcrp.2023.200192
work_keys_str_mv AT rizoriveraginnerodorico cholesterolgoalsstatinuseandresidualcardiovascularriskestimatedbysmartscorestudyofanicaraguanpopulation
AT valladaresmarionjose cholesterolgoalsstatinuseandresidualcardiovascularriskestimatedbysmartscorestudyofanicaraguanpopulation
AT toledovargashildebrandom cholesterolgoalsstatinuseandresidualcardiovascularriskestimatedbysmartscorestudyofanicaraguanpopulation
AT chavezelibeth cholesterolgoalsstatinuseandresidualcardiovascularriskestimatedbysmartscorestudyofanicaraguanpopulation
AT garciadelarochaalejandroa cholesterolgoalsstatinuseandresidualcardiovascularriskestimatedbysmartscorestudyofanicaraguanpopulation
AT urcuyohernandezluisa cholesterolgoalsstatinuseandresidualcardiovascularriskestimatedbysmartscorestudyofanicaraguanpopulation
AT menesesmercadojosedaniel cholesterolgoalsstatinuseandresidualcardiovascularriskestimatedbysmartscorestudyofanicaraguanpopulation